Here’s a bold statement: Millions of lives hang in the balance as heart disease and diabetes continue to ravage communities worldwide, but a game-changing opportunity has just emerged. MTPConnect, in partnership with the Medical Research Future Fund, has launched a new funding round under its Targeted Translation Research Accelerator (TTRA) initiative, specifically targeting medical device innovations for these devastating conditions. But here's where it gets controversial: while funding is critical, the real challenge lies in ensuring these innovations reach those who need them most—fast. This initiative aims to bridge that gap by offering non-dilutive funding of up to $1 million to Australian small to medium enterprises (SMEs), including startups and spin-outs, working on groundbreaking medical devices to prevent, diagnose, treat, or manage cardiovascular disease and diabetes complications (both Type 1 and Type 2). And this is the part most people miss: applicants must provide a cash co-contribution, a detail that could make or break their chance at securing this life-changing support. Applications close on 30 March 2026 at 4:00pm AEDT, so time is of the essence. According to MTPConnect CEO Stuart Dignam, "Access to funding remains the biggest hurdle for innovators, especially in the medtech space, and this round is designed to tackle that head-on." With the TTRA already backing 34 projects, this accelerator is a hot ticket for emerging life science companies. Here’s the kicker: through partnerships with in-house specialists and industry leaders, selected companies gain access to world-class expertise to achieve commercial proof-of-concept. But is this enough to revolutionize the fight against heart disease and diabetes? We want to hear from you: Do you think this funding model is the key to accelerating medical innovations, or are there deeper systemic issues that need addressing? Share your thoughts in the comments below. For those ready to seize this opportunity, an Information Session Webinar is scheduled for 4 March 2026 at 1:00pm AEDT, and detailed funding guidelines are available on the MTPConnect website. Don’t miss your chance to be part of this transformative initiative. Learn more here.
